Cargando…
An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response
INTRODUCTION: There are rare cases of Sjogren’s syndrome presenting with manifestations of encephalitis. There are also rare patients with Sjogren’s presenting with acute thrombotic thrombocytopenic purpura (TTP). There are no cases of both occurring together as the only symptoms of the syndrome. Du...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919096/ https://www.ncbi.nlm.nih.gov/pubmed/35747766 http://dx.doi.org/10.1177/19418744221079447 |
_version_ | 1784668878565015552 |
---|---|
author | Kasturiarachi, Brittany M. Alsbrook, Diana L. Crook, Jennifer Shah, Namrata |
author_facet | Kasturiarachi, Brittany M. Alsbrook, Diana L. Crook, Jennifer Shah, Namrata |
author_sort | Kasturiarachi, Brittany M. |
collection | PubMed |
description | INTRODUCTION: There are rare cases of Sjogren’s syndrome presenting with manifestations of encephalitis. There are also rare patients with Sjogren’s presenting with acute thrombotic thrombocytopenic purpura (TTP). There are no cases of both occurring together as the only symptoms of the syndrome. During the COVID-19 pandemic, more cases of autoimmunity are being described given its robust immune response. It is important to keep a wide differential about these varying clinical presentations. CASE PRESENTATION: Our patient is a 19-year-old female with a history of menorrhagia, recent COVID-19 infection, and remote suicidal ideation. She presented with headaches, vomiting, and psychosis. Her labs found platelets of 12,000 and she was soon discovered to have TTP. She was found to have contrast enhancing lesions scattered in her left hemisphere on magnetic resonance imaging as well as seizures. Her workup was negative for infection, but labs revealed a positive antinuclear antibody, elevated anti-Ro antibody (anti-SSA) and anti-La antibody (anti-SSB), and elevated COVID-19 antibodies. She was treated with antiepileptics, pulse dose steroids for 5 days, plasmapheresis, and weekly rituximab for 4 weeks. She had significant clinical improvement. CONCLUSION: Sjogren’s syndrome can have varying presentations including TTP with or without encephalitis as a presenting feature. Autoimmunity can also be triggered from COVID-19 infection. |
format | Online Article Text |
id | pubmed-8919096 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-89190962022-03-15 An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response Kasturiarachi, Brittany M. Alsbrook, Diana L. Crook, Jennifer Shah, Namrata Neurohospitalist Case Reports INTRODUCTION: There are rare cases of Sjogren’s syndrome presenting with manifestations of encephalitis. There are also rare patients with Sjogren’s presenting with acute thrombotic thrombocytopenic purpura (TTP). There are no cases of both occurring together as the only symptoms of the syndrome. During the COVID-19 pandemic, more cases of autoimmunity are being described given its robust immune response. It is important to keep a wide differential about these varying clinical presentations. CASE PRESENTATION: Our patient is a 19-year-old female with a history of menorrhagia, recent COVID-19 infection, and remote suicidal ideation. She presented with headaches, vomiting, and psychosis. Her labs found platelets of 12,000 and she was soon discovered to have TTP. She was found to have contrast enhancing lesions scattered in her left hemisphere on magnetic resonance imaging as well as seizures. Her workup was negative for infection, but labs revealed a positive antinuclear antibody, elevated anti-Ro antibody (anti-SSA) and anti-La antibody (anti-SSB), and elevated COVID-19 antibodies. She was treated with antiepileptics, pulse dose steroids for 5 days, plasmapheresis, and weekly rituximab for 4 weeks. She had significant clinical improvement. CONCLUSION: Sjogren’s syndrome can have varying presentations including TTP with or without encephalitis as a presenting feature. Autoimmunity can also be triggered from COVID-19 infection. SAGE Publications 2022-03-11 2022-07 /pmc/articles/PMC8919096/ /pubmed/35747766 http://dx.doi.org/10.1177/19418744221079447 Text en © The Author(s) 2022 |
spellingShingle | Case Reports Kasturiarachi, Brittany M. Alsbrook, Diana L. Crook, Jennifer Shah, Namrata An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response |
title | An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response |
title_full | An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response |
title_fullStr | An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response |
title_full_unstemmed | An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response |
title_short | An Immunologic Storm: A Case of Encephalitis and Thrombotic Thrombocytopenic Purpura With Underlying Likely Sjogren’s Syndrome Induced by a COVID-19 Immune Response |
title_sort | immunologic storm: a case of encephalitis and thrombotic thrombocytopenic purpura with underlying likely sjogren’s syndrome induced by a covid-19 immune response |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919096/ https://www.ncbi.nlm.nih.gov/pubmed/35747766 http://dx.doi.org/10.1177/19418744221079447 |
work_keys_str_mv | AT kasturiarachibrittanym animmunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse AT alsbrookdianal animmunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse AT crookjennifer animmunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse AT shahnamrata animmunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse AT kasturiarachibrittanym immunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse AT alsbrookdianal immunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse AT crookjennifer immunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse AT shahnamrata immunologicstormacaseofencephalitisandthromboticthrombocytopenicpurpurawithunderlyinglikelysjogrenssyndromeinducedbyacovid19immuneresponse |